Sandoz Pharmaceuticals Corp., et al.; Withdrawal of Approval of 7 Abbreviated Antibiotic Applications and 11 Abbreviated New Drug Applications

摘要

The Food and Drug Administration (FDA) is withdrawing approval of 7 abbreviated antibiotic applications (AADA's) and 11 abbreviated new drug applications (ANDA's). The holders of these applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.